Dr. Murugan is a board certified anatomic pathologist whose area of expertise is in the surgical pathology of genitourinary and bone / soft tissue tumors. He works closely with multidisciplinary teams involving urologists, orthopedicians, medical/radiation oncologists, and radiologists in providing expert care to patients with genitourinary, bone and soft tissue neoplasms. His role involves establishing accurate tissue diagnosis on biopsies and surgical excisions, a critical component in guiding treatment decisions. In addition to the clinical diagnostic role, Dr. Murugan is involved in medical student, resident and fellow education as well as translational research. He enjoys teaching and is constantly engaged with residents and fellows with interactive discussions during daily sign-outs and conferences. In acknowledgment of his contribution, he was conferred the Anatomic Pathology Teacher of the Year award in 2015, 2018 and 2021. Dr. Murugan has contributed over 80 peer-reviewed publications and has been involved as co-investigator in multiple R01 NIH grants. He has delivered numerous scientific meeting presentations, contributed to book chapters and has lectured nationally and internationally. He is an associate editor for the journal Diagnostic Pathology and member of the College of American Pathologists' Cancer Committee. He also serves as Program Director of the University of Minnesota's Surgical Pathology Fellowship Program and Medical Director of the CTSI's Biorepository and Laboratory Services.
Link to comprehensive list of publications
Murugan P, Jia L, Dinatale RG, Assel M, Benfante N, Al-Ahmadie HA, Fine SW, Gopalan A, Sarungbam J, Sirintrapun SJ, Hakimi AA, Russo P, Chen YB, Tickoo SK, Reuter VE. Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome. Mod Pathol. 2022 Jun;35(6):825-835.
Guo J, Koopmeiners JS, Walmsley SJ, Villalta PW, Yao L, Murugan P, Tejpaul R, Weight CJ, Turesky RJ. The Cooked Meat Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Hair Dosimeter, DNA Adductomics Discovery, and Associations with Prostate Cancer Pathology Biomarkers. Chem Res Toxicol. 2022 May 16;35(5):703-730.
Che M, Chaturvedi A, Munro SA, Pitzen SP, Ling A, Zhang W, Mentzer J, Ku SY, Puca L, Zhu Y, Bergman AM, Severson TM, Forster C, Liu Y, Hildebrand J, Daniel M, Wang TY, Selth LA, Hickey T, Zoubeidi A, Gleave M, Bareja R, Sboner A, Tilley W, Carroll JS, Tan W, Kohli M, Yang R, Hsieh AC, Murugan P, Zwart W, Beltran H, Huang RS, Dehm SM. Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer. Nat Commun. 2021 Nov 4;12(1):6377.
Kim JH, Megquier K, Thomas R, Sarver AL, Song JM, Kim YT, Cheng N, Schulte AJ, Linden MA, Murugan P, Oseth L, Forster CL, Elvers I, Swofford R, Turner-Maier J, Karlsson EK, Breen M, Lindblad-Toh K, Modiano JF. Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions. Mol Cancer Res. 2021 May;19(5):847-861.
Murugan P, Shukla D, Morocho J, Sciacca D, Pickard M, Smith D, Wahlsten M, Gunderson A, Konety B, Khalifa MA, Warlick C. Prostate Biopsy Processing: An Innovative Model for Reducing Cost, Test Time and Improving Diagnostic Material. Am J Clin Pathol. 2019 Nov 4;152(6):757-765.
Alanee S, Alvarado-Cabrero I, Murugan P, Kumar R, Nepple KG, Paner GP, Patel MI, Raspollini MR, Lopez-Beltran A, Konety BR. Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder. World J Urol. 2019 Jan;37(1):107-114.
Murugan P, Rao P, Tamboli P, Czerniak B, Guo CC. Primary Ewing Sarcoma / Primitive Neuroectodermal Tumor of the Kidney: A Clinicopathologic Study of 23 Cases. Pathol Oncol Res. 2018 Jan;24(1):153-159.
Fellowships, Residencies, and Visiting Engagements
Licensures and Certifications
Honors and Recognition
AddressC441 Mayo Building
420 Delaware St SE
Minneapolis, MN 55455